Czech Republic has a growing clinical trial infrastructure and EU regulatory alignment, making it a strategic entry point for HealthTech companies targeting the European market.
EU MDR compliance pathways, growing clinical trial infrastructure, lower R&D costs, aging populations creating demand. Czech Republic specifically offers:
Czech Republic has a growing clinical trial infrastructure and EU regulatory alignment, making it a strategic entry point for HealthTech companies targeting the European market.
Languages spoken: Czech, English, German. English proficiency score: 568/700 (EF EPI 2025).
Expanding a healthtech business to Czech Republic requires understanding the local regulatory landscape, talent market, and customer acquisition channels. Here's what you need to know:
As an EU member, Czech Republic follows EU-wide regulations including GDPR, making compliance straightforward for companies already operating in Europe., Czech Republic offers the full benefits of EU single-market access, including passporting rights for regulated industries.
Average tech salary in Czech Republic is $24,000/year — in line with developed European markets, reflecting high skill levels and strong English proficiency. Czech Republic scores 88/100 on our tech talent index, which measures developer density, university CS output, and English proficiency.
Internet penetration in Czech Republic is 89%, indicating a highly digital-first consumer base ready for SaaS and digital products. GDP per capita of $30,700 supports premium B2B pricing strategies.
Not sure if Czech Republic is the right market? Use our free Market Entry Scorecard to score all 28 markets against your specific product profile, or explore related entry guides below.
Our team has delivered 50+ projects across 28 markets. Book a free 30-minute strategy call and walk away with a written action plan, a custom market scorecard for your top 2 markets, and our full Expansion Playbook — total value $497, free.
Book Your Free Strategy Call →